Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Biden administration plans to expand coverage of GLP-1 drugs for Americans with Medicare & Medicaid
CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs for Americans with Medicare and Medicaid.
Biden Proposes Expanded Medicare, Medicaid Coverage of Obesity Drugs
Current rules for the Medicare and Medicaid government health insurance programs cover the use of drugs such as Mounjaro, Ozempic and Wegovy for certain conditions like diabetes, but not for obesity as a condition on its own.
Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal
The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover obesity medications, a costly and probably popular move that the Trump administration would need to endorse to become official.
Biden Proposes Medicare And Medicaid Cover Weight-Loss Drugs For Obese Americans
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new proposed rule.
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Biden to propose expanded Medicare, Medicaid coverage of obesity drugs, official says
U.S. President Joe Biden will propose expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid, which could cut out-of-pocket expenses for some by as much as 95%, a White House official said on Tuesday.
Biden administration pushes expansion of Medicare and Medicaid to cover weight loss drugs
The plans from the Department of Health and Human Services come on the heels of criticism Ozempic and other weight loss medications received by RFK Jr.
U.S. News & World Report11h
Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds
Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds By Ernie Mundell HealthDay Reporter TUESDAY, Nov.
GLP-1 weight-loss drugs might help protect kidneys
The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...
West Virginia residents struggle to afford GLP-1 weight loss drugs after state ends subsidy program
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...
5 GLP-1 marketing trends as brands jump on weight loss drug craze
As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.
MedPage Today20h
Are GLP-1 Drugs Putting an End to Bariatric Surgery?
We go into depth, covering what bariatric surgery is, who needs it, why insurance makes it so hard to get it, and, most ...
STAT20h
Inside the telehealth-fueled GLP-1 alternative market
The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...
BioSpace5h
Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability
Currently, Eli Lilly’s GLP-1 drugs Mounjaro and Zepbound (tirzepatide) are not on the FDA’s shortage list but compounded ...
This new supplement aims to support natural GLP-1 production and gut health
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
Medscape7h
GLP-1 RA Drug Class Benefits People With SLE, Lupus Nephritis
The glucose-lowering and weight-reducing drug class appears to benefit the heart and kidneys in people with lupus and lupus nephritis, independently of glucose-lowering and weight loss.
New supplement designed specifically to battle ‘Ozempic face’ and other GLP-1 side effects
Losing face? Take heart. A new supplement promises to put an end to the emaciated aesthetic of ‘Ozempic face.’ ...